InsidersTradesSigma
Browse the full record of transactions filed by ANDERSON DANIEL GRIFFITH. Director active across 1 companies, notably Sigilon Therapeutics, Inc.. Aggregated, 2 reports have been published. Total volume traded: €3.3m. The latest transaction was disclosed on 2 June 2021 (Cession). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations